Market Overview

Global Next-Generation Sequencing (NGS) Market 2018-2024 - Application of NGS in Precision Medicine & Molecular Diagnostics Opportunities


Global Next-Generation Sequencing (NGS) Market 2018-2024 - Application of NGS in Precision Medicine & Molecular Diagnostics Opportunities

PR Newswire

DUBLIN, Aug 30, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User - Global Forecasts to 2024" report has been added to's offering.

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2% during the forecast period.

Factors such as advancements in NGS platforms, declining NGS capital cost coupled with the decreasing cost of sequencing, and improving regulatory & reimbursement scenario for NGS-based diagnostic tests are expected to drive the growth of the next-generation sequencing market.

The report analyzes the global next-generation sequencing market, by product & service, technology, application, end user, and region.

On the basis of product & service, the next-generation sequencing market is segmented into pre-sequencing products & services (DNA fragmentation, end repair, A-tailing, and size selection; library preparation & target enrichment; and quality control), NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics (NGS data analysis, storage, and management).

The NGS platforms segment is further classified into Illumina (Hiseq Series, Hiseq X Ten & HiSeq X Five, Miseq Series, NextSeq 500, MiniSeq, and NovaSeq), Thermo Fisher Scientific (Ion PGM, Ion Proton, and Ion S5 & S5 XL), Pacific Biosciences (PacBio RS II and Sequel system), Oxford Nanopore Technologies, and Other Next-generation Sequencing Platforms.

The NGS consumables segment is expected to account for the largest share of the next-generation sequencing market in 2018. Advancements in sequencing technologies, growing number of sequencing procedures, and launch of easy-to-use consumables are the key factors driving the growth of the consumables segment.

Based on end user, the next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these, the academic institutes & research centers segment is expected to account for the largest share of the next-generation sequencing market in 2018, owing to the increasing number of collaborations between NGS market players and academic & research institutions, favorable funding scenario for genomic research across regions, and the development of cost-efficient NGS products and services for researchers.

North America is expected to account for the largest share of the global next-generation sequencing market in 2018, followed by Europe. The large share of North America is mainly attributed to the increasing application of NGS in diagnostics and genomics research, availability of research funding, and development of NGS data analysis solutions.

As of 2017, Illumina (US) dominated the global next-generation sequencing market through its broad product portfolio, strong geographical presence, and wide customer base across the globe. To maintain its leadership position in the market, the company has been focusing on technological advancements in the field of sequencing. Thermo Fisher Scientific (US) held the second position in the global next-generation sequencing market.

Other prominent players in this market include Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Next-Generation Sequencing (NGS): Market Overview
4.2 NGS Market, By Product & Service, 2018 vs 2024
4.3 NGS Market, By Technology, 2018 vs 2024 (USD Million)
4.4 NGS Market, By Application, 2018 vs 2024 (USD Million)
4.5 NGS Market, By End User and Region, 2018

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers Advancements in NGS Platforms ISEQ Ion Genestudio S5 Declining Costs Improving Regulatory & Reimbursement Scenario for NGS-Based Diagnostic Tests
5.2.2 Restraints End-User Budget Constraints in Developing Nations
5.2.3 Opportunities Initiatives From Government & Private Bodies for Large-Scale Sequencing Projects Application of NGS in Precision Medicine & Molecular Diagnostics NGS Data Analysis Using Big Data
5.2.4 Challenges Interpretation of Complex Data From NGS Platforms Ethical Issues
5.2.5 Industry Trends Reduction in Platform Footprint and the Development of Portable Sequencing Technology Partnerships and Collaborations for Technological Advancements in NGS Conferences and Workshops Increasing Awareness on NGS Products and Services

6 Next-Generation Sequencing Market, By Product & Service
6.1 Introduction
6.2 Pre-Sequencing Products & Services
6.2.1 Sample Preparation Dna Fragmentation, End Repair, A-Tailing, and Size Selection Library Preparation & Target Enrichment Quality Control
6.3 NGS Consumables, Platforms, & Services for Platforms
6.3.1 NGS Consumables
6.3.2 NGS Platforms Illumina Hiseq Series Hiseq X Ten & Hiseq X Five Miseq Series Nextseq 500 Miniseq Novaseq Thermo Fisher Scientific Ion PGM Ion Proton Ion S5 & S5 XL Pacific Biosciences Pacbio RS II Sequel System Oxford Nanopore Technologies Other Next-Generation Sequencing Platforms
6.3.3 Services for NGS Platforms
6.4 Sequencing Services
6.4.1 Exome & Targeted Re-Sequencing and Custom Panels
6.4.2 RNA-Seq
6.4.3 Whole-Genome Sequencing & De Novo Sequencing
6.4.4 Other Sequencing Services
6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
6.5.1 NGS Data Analysis Software & Workbenches
6.5.2 NGS Data Analysis Services
6.5.3 NGS Storage, Management, and Cloud Computing Solutions

7 Next-Generation Sequencing Market, By Technology
7.1 Introduction
7.2 Sequencing By Synthesis
7.3 Ion Semiconductor Sequencing
7.4 Single-Molecule Real-Time Sequencing
7.5 Nanopore Sequencing
7.6 Other Sequencing Technologies

8 Next-Generation Sequencing Market, By Application
8.1 Introduction
8.2 Diagnostics
8.2.1 Cancer Diagnostics
8.2.2 Infectious Disease Diagnostics
8.2.3 Reproductive Health Diagnostics
8.2.4 Other Diagnostic Applications
8.3 Drug Discovery
8.4 Agricultural & Animal Research
8.5 Other Applications

9 Next-Generation Sequencing Market, By End User
9.1 Introduction
9.2 Academic Institutes & Research Centers
9.3 Hospitals & Clinics
9.4 Pharmaceutical & Biotechnology Companies
9.5 Other End Users

10 Next-Generation Sequencing Market, By Region

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 Product Launches, Product Enhancements, and Service Launches
11.3.2 Agreements, Partnerships, Collaborations, and Contracts
11.3.3 Mergers and Acquisitions
11.3.4 Expansions

12 Company Profiles

  • 10x Genomics
  • Agilent Technologies, Inc.
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • BGI
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Genewiz
  • Illumina, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Cision View original content with multimedia:

SOURCE Research and Markets

View Comments and Join the Discussion!